Fusion Pharmaceuticals Inc

PCI Pharma Service Canada Inc, located in Burlington, Canada, is a world-leading Contract Development and Manufacturing Organization (CDMO) that specializes in drug product development and commercialization. With a global presence and a team of 4300 professionals across 30 GMP facilities, they offer integrated speed solutions to simplify the supply chain and bridge the gap between life-changing therapies and patients. Driven by a commitment to environmental, social, and governance (ESG) principles, PCI Pharma Service Canada Inc provides a comprehensive range of pharmaceutical services, from early development stages to commercial launch and beyond. Their innovative approach and dedication to advancing healthcare make them a respected industry leader in the field of drug development and manufacturing. Generated from their website

Accurex Health Care Manufacturing Inc, located in Brantford, Canada, is a reputable company specializing in providing a range of healthcare products and services. With a strong emphasis on quality assurance, Accurex is dedicated to meeting the needs of its clients and ensuring the highest standards of excellence. Offering a user login feature for convenient access to services, Accurex also prioritizes accessibility by including an AODA link on its website. With a commitment to quality and customer satisfaction, Accurex Health Care Manufacturing Inc continues to be a trusted name in the healthcare industry. Generated from their website

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company based in Oakville, Ontario, dedicated to serving patients by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products. The company focuses on addressing the needs of patients through its innovative offerings and commitment to quality. Recently, ANI Pharmaceuticals has been active in the financial sector, reporting record first-quarter results for 2025 and participating in industry conferences, highlighting its ongoing growth and strategic initiatives. With a robust pipeline of products, ANI Pharmaceuticals continues to enhance its position in the biopharmaceutical landscape. Generated from the website